cisatracurium besylatedrugHigh PriorityActive

Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose via

cisatracurium besylate Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose via recalled by FDA. Subpotent product:out of specification assay results observed during long term stability testing.

By RecallRadar Editorial Team

Sourced from FDA. Last reviewed March 4, 2026.

This recall involves safety concerns. Take action promptly.

✨ Plain-English Summary

Is This Recall Still Active?

Status: Yes - Active

This recall is currently active. If your device matches the affected models, follow the official instructions as soon as possible.

Source & Verification

This page summarizes the official notice and keeps key facts easy to verify.

Official source: FDA
Announced by source: November 26, 2025
Last reviewed by RecallRadar: March 4, 2026

What You Should Do

1## Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose via Agency: FDA | Category: drug Reason: Subpotent product:out of specification assay results observed during long term stability testing. What to do:
2Stop using the product if your lot/model matches.
3Check the FDA notice for specifics.
4Follow remedy instructions.

Open Official Recall Notice Get Alerts for cisatracurium besylate Devices

What's Being Recalled

Quoted source excerpt from the official notice.

Subpotent product:out of specification assay results observed during long term stability testing.

Who's Affected

Specific models and identifiers listed in the source notice:

Model #1

Lot #: A250020, Exp Date 06/30/2026

#	Model
1	Lot #: A250020, Exp Date 06/30/2026

Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.

Frequently Asked Questions

Is my cisatracurium besylate device affected?

Check the affected models section on this page. The official notice currently lists Lot #: A250020, Exp Date 06/30/2026.

What is the remedy for this recall?

## Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose via Agency: FDA | Category: drug Reason: Subpotent product:out of specification assay results observed during long term stability testing. What to do: 1. Stop using the product if your lot/model matches. 2. Check the FDA notice for specifics. 3. Follow remedy instructions.

Where can I verify recall details?

Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Keep browsing with these internal hubs: cisatracurium besylate recall hub and Food & Drug recall hub.